Somerville, MA, United States of America

Victor S Gehling

This inventor holds 32 USPTO granted patents and 8 published patent applications, plus 4 CIPO patents and 19 EPO patents, primarily in Methyl Modifying Enzymes. Top assignees: Constellation Pharmaceuticals, Inc., Genentech, Inc.. Active years: 2014-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Victor S Gehling. Retrieved from https://idiyas.com/inventor/victor-s-gehling

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 32 (Patent Applications = 8)

% Patents Active = 100.0

CIPO Patents = 4 (Patent Applications = 5)

EPO Patents = 19 (Patent Applications = 23)

Average Co-Inventor Count = 5.8

ph-index = 7

Forward Citations = 149(Granted Patents)

Location History:

Cambridge, MA (US) (2019)
Somerville, MA (US) (2014 - 2023)

Company Filing History:

32 out of 56

Constellation Pharmaceuticals, Inc.

where one patent can have more than one assignee

Years Active: 2014-2026

Loading Chart...

Areas of Expertise:

Methyl Modifying Enzymes

LSD1 Inhibitors

Therapeutic Compounds

Histone Demethylase Inhibitors

Bromodomain Inhibitors

Pyrazolo Compounds

Indole Derivatives

Crystalline Forms

32 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12612390 - Modulators of methyl modifying enzymes, compositions and uses thereof (2026-04-28),

2. 12516040 - Crystalline forms of 7-chloro-2-(4-3-methoxyazetidin-1-yl)cyclohexyl)-2,4-dimethyl-N-((6-methyl-4-(methylthio)-2-oxo-1,2-dihydropyridin-3-yl)methyl)benzo[d][1,3]dioxole-5-carboxamide (2026-01-06),

3. 12172990 - Modulators of TREX1 (2024-12-24),

4. 11547695 - LSD1 inhibitors and medical uses thereof (2023-01-10),

5. 11459315 - Modulators of methyl modifying enzymes, compositions and uses thereof (2022-10-04),

6. 11274095 - Modulators of methyl modifying enzymes, compositions and uses thereof (2022-03-15),

7. 11013718 - LSD1 inhibitors and medical uses thereof (2021-05-25),

8. 10689371 - Modulators of methyl modifying enzymes, compositions and uses thereof (2020-06-23),

9. 10577350 - Crystalline forms of (R)-N-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide (2020-03-03),

10. 10526287 - LSD1 inhibitors and uses thereof (2020-01-07),

11. 10517849 - LSD1 inhibitors and medical uses thereof (2019-12-31),

12. RE47428 - Modulators of methyl modifying enzymes, compositions and uses thereof (2019-06-10),

13. 10301253 - Therapeutic compounds and uses thereof (2019-05-28),

14. 10280149 - Therapeutic compounds and uses thereof (2019-05-07),

15. 10202354 - Therapeutic compounds and uses thereof (2019-02-12),

Title: Victor S Gehling: Pioneering Innovations in Medical Treatments

Introduction:

Victor S Gehling, a prolific inventor based in Somerville, MA, has made significant contributions to the field of medical research and pharmacology. With a remarkable 29 patents to his name, Gehling's work has focused on developing novel compounds and pharmaceutical compositions for treating a range of diseases and conditions.

Latest Patents:

Two of Gehling's latest patents showcase his innovative approach to developing treatments for complex medical conditions. The first patent revolves around LSD1 inhibitors and their medical applications. These compounds, along with their pharmaceutical compositions, have shown promising results in combating diseases associated with LSD1.

The second patent highlights Gehling's work on modulators of methyl modifying enzymes. The compounds described in this patent, along with their pharmaceutical salts and compositions, have demonstrated effectiveness in treating conditions linked to methyl modifying enzymes.

Career Highlights:

Gehling's expertise and dedication have led him to collaborate with renowned companies in the pharmaceutical industry. He has made significant contributions during his tenure at Constellation Pharmaceuticals, Inc. and Genentech, Inc., where he played a pivotal role in developing cutting-edge medical treatments.

Collaborations:

Throughout his career, Gehling has collaborated closely with accomplished professionals in the field. Notable colleagues include Brian K Albrecht and Jean-Christophe P Harmange, who have worked alongside Gehling to drive innovation and push the boundaries of medical research.

Conclusion:

In conclusion, Victor S Gehling stands as a pioneering figure in the realm of medical innovations. His relentless pursuit of developing novel compounds and pharmaceutical solutions has not only enriched the field of pharmacology but also offered hope to those battling complex diseases. Gehling's legacy serves as an inspiration for future inventors and researchers looking to make a lasting impact on healthcare and well-being.

Profile summary based on public USPTO records.